Luteolin

Bioss Antibodies

Luteolin [491-70-3]

16

Research Use Only

>98%

Anticancer and antimetastatic agent that induces apoptosis and modulates autophagy. Shown to inhibits kinase signalling, including PKC(epsilon) and Src kinase, HDAC, Phosphatidylinositol 3-kinase (PI3K) / Akt and p90 ribosomal S6 kinase (RSK1/RSK2). Topoisomerase I Inhibitor. Anti-inflammatory agent that inhibits 15-Lipoxygenase (15-LOX) and IL-6 production. Antioxidant. Free radical scavenger. Antiadipogenic agent, that inhibits PPAR-gamma, fatty acid synthase (FAS) and alpha-Glucosidase. Neuroprotective. Monoamine transporter activator and inhibitor of phosphodiesterases 1-5 (PDE1-5). Shown to selectively inhibits chymotrypsin-like and trypsin-like proteasome catalytic activity.

-20°C

12352200